iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia.

MLA

Balakrishnan, Dhivya, et al. “ITIND: The Second-Generation Temporary Implantable Nitinol Device for Minimally Invasive Treatment of Benign Prostatic Hyperplasia.” Therapeutic Advances in Urology, vol. 12, Jan. 2020, pp. 1–5. EBSCOhost, https://doi.org/10.1177/1756287220934355.

APA

Balakrishnan, D., Jones, P., & Somani, B. K. (2020). iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia. Therapeutic Advances in Urology, 12, 1–5. https://doi.org/10.1177/1756287220934355

Chicago

Balakrishnan, Dhivya, Patrick Jones, and Bhaskar K. Somani. 2020. “ITIND: The Second-Generation Temporary Implantable Nitinol Device for Minimally Invasive Treatment of Benign Prostatic Hyperplasia.” Therapeutic Advances in Urology 12 (January): 1–5. doi:10.1177/1756287220934355.